Adalimumab vs Ravulizumab

## Adalimumab vs Ravulizumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Ravulizumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Ravulizumab — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Ravulizumab — Antibody.